23andMe Stock Discussion

Struggling genetic-testing firm $23andMe(ME.US)$ rose more than 15% intraday Friday after reportedly beating analyst estimates on fiscal Q4 revenue.
ME rose as much as 16.7% to 59.48 cents per share, although the stock later retreated to 55.39 cents shortly before noon ET, ahead 8.7% on the day.
Shares gained ground after the firm reported Thursday after the bell that it lost 43 cents per share on $64 million in revenue in the three...

$Nasdaq Composite Index(.IXIC.US)$
$23andMe(ME.US)$ ✈️👌target 1$ news great

$23andMe(ME.US)$ ✈️✈️👀news great target 1$

$23andMe(ME.US)$ good news ✈️✈️✈️👀

$23andMe(ME.US)$ buy for a long term

$23andMe(ME.US)$ buy

$23andMe(ME.US)$ someone wants it drive up price old owner wants it now read news.

$23andMe(ME.US)$ bargain sell later, buy it now.